Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/90884
Title: | Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration | Authors: | Gonçalves, Joana Alves, Gilberto Carona, Andreia Bicker, Joana Vitorino, Carla Falcão, Amílcar Fortuna, Ana |
Keywords: | Zonisamide; Epilepsy; Intranasal; Mice; Nose-to-brain; Pharmacokinetics | Issue Date: | 25-Mar-2020 | Publisher: | Springer Nature | Project: | CENTRO-01-0145-FEDER-03075 POCI-01-0145- FEDER-030478 |
Serial title, monograph or event: | Pharmaceutical Research | Volume: | 37 | Issue: | 4 | Abstract: | Zonisamide clinical indications are expanding beyond the classic treatment of epileptic seizures to Parkinson's disease and other neurodegenerative diseases. However, the systemic safety profile of zonisamide may compromise its use as a first-line drug in any clinical condition. Since zonisamide is marketed as oral formulations, the present study aimed at exploring the potential of the intranasal route to centrally administer zonisamide, evaluating the systemic bioavailability of zonisamide and comparing its brain, lung and kidney pharmacokinetics after intranasal, oral and intravenous administrations. | URI: | https://hdl.handle.net/10316/90884 | ISSN: | 0724-8741 1573-904X |
DOI: | 10.1007/s11095-020-02786-z | Rights: | openAccess |
Appears in Collections: | I&D CQC - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Pharm_Res.pdf | 805.3 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
8
checked on Nov 17, 2022
WEB OF SCIENCETM
Citations
20
7
checked on Nov 15, 2022
Page view(s)
234
checked on Oct 9, 2024
Download(s)
606
checked on Oct 9, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License